Prostate cancer survivors benefit from non-vigorous activity, walking
the ONA take:
After prostate cancer diagnosis, at least five hours of non-vigorous activity or 3 hours of walking is positively associated with better hormone and vitality functioning, according to a study published in the Journal of Cancer Survivorship.
Siobhan Phillips, PhD, MPH, at Northwestern University Feinberg School of Medicine and fellow researchers prospectively examined 1,917 men diagnosed with non-metastatic prostate cancer in the Health Professionals Follow-Up Study.
They looked at associations between activity and sedentary behavior after prostate cancer diagnosis in terms of health-related quality of life.
The researchers found that, upon adjusting for confounders, higher duration of non-vigorous and walking activity were associated with higher vitality and hormonal functioning scores.
The effects approached clinical significance for men in the highest versus lowest categories, with survivors who walked at least 90 minutes a week at a normal or faster pace reporting higher scores than men who walked less than 90 minutes a week at an easy pace.
Total activity was found to be associated with higher hormone and vitality functioning in men who were at least five years post-treatment and had more advanced disease.
“Encouraging men to engage in non-vigorous activity and walking may be helpful for managing prostate cancer-related health-related quality of life,” the authors concluded.
After prostate cancer diagnosis, at least five hours of non-vigorous activity or 3 hours of walking is beneficial.
- Acupuncture Improves Postoperative Symptoms in Women Undergoing Surgery for Breast Cancer
- Prehabilitation Program Improves Preoperative Fitness in Patients With Colorectal Cancer
- Alcohol Consumption, Particularly White Wine, Associated With Increased Risk of Melanoma
- Combination of Gemcitabine and New CHK1 Inhibitor Is Effective in Soft Tissue Sarcomas
- Omitting RT in Certain Older Women With Early Breast Cancer is Safe
- Exercise is as Effective in Treating Metastatic Prostate Cancer as Medication
- Walnut Consumption Changes Gut Microbiome, Decreases Growth of Colon Cancer in Mice
- Vaccine Enters Phase I Study for Safety and Effectiveness in Multiple Myeloma
- Timing Chemotherapy Administration to Circadian Rhythm Improves Drug Effectiveness
- New Therapy Blocks Breast Cancer Cells From Entering and Hiding in Bone Marrow to Form Latent Metastases
- Community Breast Navigation Program Improved Breast Screening Rates in Underserved African American and Latino Women
- Live-streamed Videos Address End-of-Life Planning, Decision-making
- Metastatic Disease Linked to Patients Reporting Diminished QoL
- History of Bilateral Salpingo-oophorectomy, Hormone Replacement Therapy Are Predictive of Breast Density at Cancer Diagnosis
- Mammographically Occult Contralateral Breast Cancer Detection is Effective With Preoperative MRI
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|